@FiercePharma: Report: Livestock research lab prioritizes profits over animal health. FierceAnimalHealth article | Follow @FiercePharma
@EricPFierce: UK's MHRA expands its ban of Wockhardt's plant in Chikalthana, India to include all APIs. FiercePharmaManufacturing article | Follow @EricPFierce
@CarlyHFierce: Incoming Takeda chief ready to jump on the M&A train with reorg in place. Report | Follow @CarlyHFierce
> Sanofi ($SNY) and Genzyme were granted marketing authorization from the European Commission (EC) for Gaucher drug Cerdelga. Release (PDF)
> Counterfeit versions of Eli Lilly's ($LLY) erectile dysfunction drug Cialis were found in the mail en route to a customer in the U.S., the FDA said on Wednesday. Story
> Keryx Biopharmaceuticals ($KERX) priced an offering of 9 million shares at $12 per share, with expected proceeds of $110 million. More
> Biogen Idec ($BIIB) snagged the number one spot on a list of the world's most sustainable corporations, outranking more than 4,600 companies with a market cap over $2 billion. Article
> Pakistan's pharma industry is calling for a 15% price hike for generic and branded drugs to protect it from financial losses. Story
> The market for colorectal cancer drugs is expected to grow to $9.4 billion by 2020 despite looming patent expirations for Roche's ($RHHBY) Avastin and Merck KGaA's Erbitux, according to a new report from GBI Research. More
Medical Device News
@FierceMedDev: SV Bio changes name to Lifecode, plans rollout of NGS cancer assay. FierceDiagnostics story | Follow @FierceMedDev
@VarunSaxena2: Celator's delivery platform results in FDA's fast-track designation for its cancer candidate. FierceDrugDelivery article | Follow @VarunSaxena2
@EmilyWFierce: J&J settles the score with over 100 vaginal mesh plaintiffs. More | Follow @EmilyWFierce
> Welch Allyn buys eye exam provider, demonstrating device industry's growing interest in services. More
> China announces landmark medical device GSP rules. Report
Biotech News
@FierceBiotech: China's Innovent banks $100M to cash in on the biosimilar boom. Report | Follow @FierceBiotech
@JohnCFierce: So Martin Pule, who got his start with Brenner at Baylor on CAR-T ($CELG, $BLUE) went on the Cellectis deal ($ALCLS) is now CSO at Autolous. | Follow @JohnCFierce
@DamianFierce: @IAmBiotech weighs in on Obama's precision medicine plan. More | Follow @DamianFierce
> Kite expands its immuno-oncology brain trust in the CAR-T footrace. Article
> The CAR-T brain war: Scientific trailblazer inspires a $45M biotech startup. Story
Vaccines News
> After rocky flu season, vaccinemakers may want to follow Novartis' lead. Story
> Disneyland measles outbreak adds fuel to heated anti-vaccination debate. Item
> J&J forms consortia to accelerate Ebola vaccine development, gets €100M boost from IMI. News
> Study: GSK's malaria vaccine may not be effective when used with bed nets. More
> MSF urges GSK, Pfizer to slash pneumococcal vaccine prices. Report
Pharma Manufacturing News
> Manufacturing key to getting more effective flu jabs to market faster. Story
> Gulf Pharmaceutical commits to sterile injectable plant in Ethiopia. Report
> FDA finds more counterfeit Cialis, warns consumers. Article
> U.K. expands Wockhardt ban. More
> Biologics manufacturing helps Lonza to early turnaround. Story
And Finally… Women with Alzheimer's disease who had a prostate cancer drug added to their regimen showed stable cognition for a year, according to a new study from researchers at the University of Wisconsin-Madison. More